Gilead Sciences has agreed to receive Immunomedics for about $21 billion, offering it a opportunity blockbuster breast cancer drug to...
Gilead
Gilead Sciences has agreed to get drugmaker Forty Seven for $four.9 billion in funds, the corporations declared Monday. Gilead will...